metricas
covid
Buscar en
Psiquiatría Biológica
Toda la web
Inicio Psiquiatría Biológica Huntington latente desenmascarado por aripiprazol
Journal Information
Vol. 32. Issue 2. (In progress)
(April - June 2025)
Share
Share
Download PDF
More article options
Vol. 32. Issue 2. (In progress)
(April - June 2025)
Caso clínico
Huntington latente desenmascarado por aripiprazol
Latent Huntington's unmasked by aripiprazole
Elena Blanco-Martin
Corresponding author
elena.blancom@salud-juntaex.es

Autor para correspondencia.
, Maria Nieto-Compán, Jorge López-Álvarez
Servicio de Psiquiatría, Hospital Universitario de Badajoz, Bajadoz, España
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (1)
Tabla 1. Fármacos, acción central, efecto secundario y sospecha clínica
Resumen

La enfermedad de Huntington es un trastorno neurodegenerativo hereditario cuyos síntomas incluyen trastornos del movimiento, deterioro cognitivo y síntomas psiquiátricos, y suelen aparecer entre los 30 y 50 años. Se presenta el caso de una mujer de 31 años, ingresada por primera vez en psiquiatría por un episodio depresivo con ideación suicida. Previamente evaluada por neurología, sin diagnóstico claro, por alteraciones del movimiento, estereotipias y descoordinación motora. La presencia de síntomas motores durante el ingreso motivó una interconsulta a neurología. Se diagnosticó síndrome extrapiramidal y se sospechó enfermedad de Huntington, confirmada posteriormente mediante estudios genéticos. Tras ajustar la medicación y eliminar aripiprazol, mejoraron los síntomas depresivos y motores. Este caso resalta la importancia de considerar enfermedades neurodegenerativas cuando se presentan síntomas psiquiátricos, motores y cognitivos simultáneamente. Además, se muestra cómo los efectos secundarios de los fármacos pueden desenmascarar enfermedades latentes.

Palabras clave:
Aripiprazol
Huntington
Corea
Agonista
Abstract

Huntington's disease is an inherited neurodegenerative disorder whose symptoms include movement disorders, cognitive impairment, and psychiatric symptoms, and usually appear between the ages of 30 and 50. We present the case of a 31-year-old woman admitted to Psychiatry for the first time due to a depressive episode with suicidal ideation. Previously evaluated by Neurology without a clear diagnosis, due to movement alterations, stereotypies and motor incoordination. The presence of motor symptoms during admission led to an interconsultation with the Neurology Department. Extrapyramidal syndrome was diagnosed and Huntington's disease was suspected, later confirmed by genetic studies. After adjusting the medication and eliminating aripiprazole, depressive and motor symptoms improved. This case highlights the importance of considering neurodegenerative diseases when psychiatric, motor, and cognitive symptoms are present simultaneously. In addition, it shows how the side effects of drugs can unmask latent diseases.

Keywords:
Aripiprazole
Huntington
Corea
Agonist

Article

These are the options to access the full texts of the publication Psiquiatría Biológica
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Psiquiatría Biológica

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.psiq.2023.100440
No mostrar más